225 related articles for article (PubMed ID: 21494890)
1. CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation.
Jerjes W; Upile T; Hamdoon Z; Al-Khawalde M; Morcos M; Mosse CA; Hopper C
Lasers Med Sci; 2012 Jan; 27(1):169-79. PubMed ID: 21494890
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy outcome for oral dysplasia.
Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
Lasers Surg Med; 2011 Mar; 43(3):192-9. PubMed ID: 21412802
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
4. Management of oral leukoplakia by laser surgery: relation between recurrence and malignant transformation and clinicopathological features.
Ishii J; Fujita K; Munemoto S; Komori T
J Clin Laser Med Surg; 2004 Feb; 22(1):27-33. PubMed ID: 15117484
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
Hamadah O; Thomson PJ
Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
[TBL] [Abstract][Full Text] [Related]
6. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
12. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery.
Yang SW; Lee YS; Chang LC; Yang CH; Luo CM
BMC Oral Health; 2021 Jan; 21(1):45. PubMed ID: 33509189
[TBL] [Abstract][Full Text] [Related]
13. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
14. Laser surgery as a treatment for oral leukoplakia.
Ishii J; Fujita K; Komori T
Oral Oncol; 2003 Dec; 39(8):759-69. PubMed ID: 13679199
[TBL] [Abstract][Full Text] [Related]
15. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
Thomson PJ; Goodson ML; Smith DR
J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
18. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up.
Del Corso G; Gissi DB; Tarsitano A; Costabile E; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Jul; 43(6):763-8. PubMed ID: 25979576
[TBL] [Abstract][Full Text] [Related]
19. [Oral leukoplakia. A retrospective study of clinical and histological data].
Bornstein MM; Benguerel MC; Magnin P; Meier E; Buser D
Schweiz Monatsschr Zahnmed; 2004; 114(7):680-6. PubMed ID: 15360103
[TBL] [Abstract][Full Text] [Related]
20. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]